BioSciDB Alternative
Why do former BioSciDB customers love DealForma?DealForma is a high-quality, detailed, and user-friendly alternative to BioSciDB. BioSciDB was acquired by Evaluate.
Finally, a deals database built specifically for biopharma.
DealForma stands out as the best in biopharma deal data with its comprehensive coverage of biotech and pharma licensing and funding transactions by providing a superior experience when it comes to deal terms. We focus on delivering high-quality deal data so you can have confidence that you are getting complete and accurate information for your biopharma business development deal comps and benchmark research.
Comprehensive Coverage
DealForma provides the most extensive coverage of biopharmaceutical transactions, including licensing deals, asset purchases, mergers, acquisitions, research partnerships, and funding rounds, ensuring you have access to a vast repository of relevant data.
In-Depth Analytics
With granular and relevant filters, DealForma allows you to delve into transaction details, track trends, and gain valuable insights into deal structures, valuations, therapeutic areas, and key players, enabling strategic planning, market analysis, and competitive intelligence.
Advanced Deal Monitoring
Business developers are switching to DealForma for its advanced deal monitoring capabilities. The platform enables you to set up alerts for specific criteria, such as target companies, indications, or modalities so you stay informed about the latest developments and deal opportunities.
Compare DealForma vs. BioSciDB
Comparison based on customer feedback and public information gathered June 2023 to the best of our knowledge. We understand the world is constantly changing, so if you see we missed a feature or made a mistake, let us know.
DealForma vs. BioSciDB
BioSciDB specializes in deals with unredacted contracts and tagged contract provisions, offering valuable insights into the terms and conditions of agreements in the biopharma industry. DealForma excels in analyzing global deal and funding profiles with attached source documents providing you up-to-date information. Additionally, DealForma offers you data on companies and drug sales figures all in a modern, powerful, and intuitive interface.
Why are biopharma and finance companies switching to DealForma?
"DealForma is a Better Deal Database"
We keep hearing from business developers who have tried other databases and DealForma. They are switching to DealForma because of the deal-focused filters and the ability to quickly pull relevant deal comps knowing the content is high-quality. This saves them time when creating reports because the information is verified and up-to-date.
Intuitive, Modern Interface
You know that biopharma business development is full of complex terminology. But you shouldn’t have to remember how a database codes things. DealForma designed its platform from the ground up to make finding the most relevant information fast and easy. DealForma’s granular filters give you the confidence in working with the right data.
Intentional Biopharma Deal Curation
Analysts at DealForma have experience reading thousands of deal and funding announcements and company filings. Teams assigned to each segment look for key terms to separate out from a noisy news flow. And they do this manually, every day, so you can quickly filter through decades of carefully curated, relevant transaction profiles.
Included Analyst Support
DealForma goes beyond a mere database by providing you 20 hours of analyst time per year included with your subscription for you to leverage the expertise of skilled professionals to assist you in data interpretation, perform custom analyses, and provide valuable insights tailored to specific business needs.




21,135
Licensing Deals
4,145
M&A
5,766
Other Deals
21,479
Funding Rounds
34,717
Company Profiles
26,805
Drug Sales Figures
All of this by stage, disease indication, modality, target...